The Ile164 β2-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to Gs-Reference-Cited by-同舟云学术

The Ile164 β2-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to Gs

Published:2001-06 Issue:3 Volume:421 Page:141-147
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Green Stuart A,Rathz Deborah A,Schuster Amy J,Liggett Stephen B

Publisher

Elsevier BV

Subject

Pharmacology

Reference33 articles.

1. Salmeterol, a novel, long-acting β2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo;Ball;Br. J. Pharmacol.,1991

2. Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?;Beasley;J. Allergy Clin. Immunol.,1999

3. An operational model of pharmacological agonism: the effect of E/[A]curve shape on agonist dissociation constant estimation;Black;Br. J. Pharmacol.,1985

4. Stable activation and desensitization of β2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite;Clark;Mol. Pharmacol.,1996

5. Bronchodilatation;Derom,1997

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coevolution-Driven Method for Efficiently Simulating Conformational Changes in Proteins Reveals Molecular Details of Ligand Effects in the β2AR Receptor;The Journal of Physical Chemistry B;2023-11-10

2. Coevolution-driven method for efficiently simulating conformational changes in proteins reveals molecular details of ligand effects in the β2AR receptor;2023-07-21

3. The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive update;Expert Opinion on Drug Metabolism & Toxicology;2023-05-04

4. Loss of a water-mediated network results in reduced agonist affinity in a β2-adrenergic receptor clinical variant;Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics;2021-04

5. Pharmacogenomics and pharmacoepigenomics: Impact on therapeutic strategies;The Future of Pharmaceutical Product Development and Research;2020